Avagliano Mark - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 18, 2024, Avagliano Mark's relationship to G1 Therapeutics, Inc. (GTHX) is Officer (Chief Business Officer), and currently has 262,645 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GTHX insiders.
Data Source: SEC.
Avagliano Mark - Insider Non-Derivative Transactions of GTHX Common Stock
Avagliano Mark - Insider Non-Derivative Transactions at GTHX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 19, 2024 | U -- (Common Stock) | 26035 | 0 | 0 |
| Sep 19, 2024 | Disposition -- (Common Stock) | 236610 | 0 | 26035 |
| Sep 19, 2024 | Acquisition -- (Common Stock) | 20600 | 0 | 262645 |
| Jul 6, 2024 | Sell -- (Common Stock) | 2638 | 2.51 | 242045 |
| Jul 2, 2024 | Acquisition -- (Common Stock) | 35000 | 0 | 244683 |
| May 14, 2024 | Sell -- (Common Stock) | 8151 | 4.79 | 209683 |
| Mar 21, 2024 | Acquisition -- (Common Stock) | 100000 | 0 | 217834 |
| Jan 5, 2024 | Sell -- (Common Stock) | 721 | 2.94 | 117834 |
| Jan 4, 2024 | Sell -- (Common Stock) | 2602 | 3.12 | 118555 |
| Jan 4, 2024 | Sell -- (Common Stock) | 758 | 3.12 | 121157 |
| Jan 4, 2024 | Acquisition -- (Common Stock) | 44760 | 0 | 121915 |
| May 11, 2023 | Acquisition -- (Common Stock) | 35000 | 0 | 77155 |
| Jan 4, 2023 | Acquisition -- (Common Stock) | 20600 | 0 | 42155 |